Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.
Title : TBI diagnostic and therapeutics
Jonathan Eskenazi, Cedars Sinai Medical Center, United States
Title : Understanding pediatric traumatic brain injury across the childhood lifespan
Juliet K Haarbauer Krupa, Emory University School of Medicine, United States
Title : Is brain just a machine?
Luiz Moutinho, University of Suffolk, United Kingdom
Title : From ontology fingerprints to BRAINCELL-AID: Literature-driven gene function and brain cell annotation
W Jim Zheng, University of Texas Health Science Center at Houston, United States
Title : Managing healthcare transformation towards intelligent and ethical personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Compromised psychophysical orientation to the vertical gravitational constant and its role in the emergence of complex neurological and mental disorders
Ken Ware, Neurotricional Sciences Institute, Australia